Jeffrey L. Goldberg, MD, PhD

Co-founder and Director, Board of Managers 

Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University. His focus is on regenerative medicine in eye and vision research,  and on developing novel molecular, stem cell, and nanotherapeutics approaches for eye repair. Jeff completed his clinical training in ophthalmology and glaucoma at the Bascom Palmer Eye Institute. He received his BS magna cum laude from Yale, and his MD and PhD from Stanford .

Roger A. Goldberg, MD, MBA

Co-founder and Chief Medical Officer

Dr. Roger Goldberg is a vitreoretinal (VR) surgeon and serial entrepreneur with expertise in clinical trial design and implementation. He did his clinical training in ophthalmology at the Bascom Palmer Eye Institute and VR fellowship at Tufts University. Previously, Roger worked for McKinsey & Co. in healthcare consulting. He received his BA, MD, and MBA from Yale.

Noelia J. Kunzevitzky, PhD

Chief Operating Officer

Dr. Noelia Kunzevitzky is a scientist focused on innovation in ophthalmology and regenerative medicine. She has experience in cell manufacturing, pre-clinical development, regulatory project management, and clinical trials. Previously, she was Director of Quality and Regulatory Affairs at a multinational medical device company. Noelia obtained her BS at the Universidad Nacional de Cordoba in Argentina, and completed her PhD in cell biology and postdoctoral training in bioinformatics at the University of Miami.